131 related articles for article (PubMed ID: 16821707)
1. New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2006; 51(1):25-6. PubMed ID: 16821707
[TBL] [Abstract][Full Text] [Related]
2. New antimycobacterial S-alkylisothiosemicarbazones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
4. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
5.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Disratthakit A; Doi N
Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403
[TBL] [Abstract][Full Text] [Related]
7.
Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?
Ho II; Chan CY; Cheng AF
Antimicrob Agents Chemother; 2000 Jan; 44(1):39-42. PubMed ID: 10602720
[TBL] [Abstract][Full Text] [Related]
9. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
10. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
11. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis.
Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W
Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533
[TBL] [Abstract][Full Text] [Related]
12. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of quinolones and macrolides against mycobacteria.
Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime.
Abate G; Hoffner SE
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):119-22. PubMed ID: 9294701
[TBL] [Abstract][Full Text] [Related]
15. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
Barrett MS; Jones RN; Erwin ME; Koontz FP
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
[TBL] [Abstract][Full Text] [Related]
17. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
Yamori S; Ichiyama S; Shimokata K; Tsukamura M
Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364
[TBL] [Abstract][Full Text] [Related]
18. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
19. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.
Otchere ID; Asante-Poku A; Osei-Wusu S; Aboagye SY; Yeboah-Manu D
Int J Mycobacteriol; 2017; 6(1):70-75. PubMed ID: 28317808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
